Evidence map›Paper›PMID 20696932›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Vitamin K epoxide reductase prefers ER membrane-anchored thioredoxin-like redox partners.

Sol Schulman, Belinda Wang, Weikai Li, Tom A Rapoport

Open access · greenAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 146 citations in OpenAlex.

  1. Giant viruses encode vitamin K-based redox modules for lipid modification.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Oxidative protein folding and CaCellular and molecular life sciences : CMLS · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Human Vitamin K Epoxide Reductase as a Target of Its Redox Protein.International journal of molecular sciences · 2022
    Article
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Sol SchulmanDepartment of Cell Biology, Harvard Medical School, Howard Hughes Medical Institute, 240 Longwood Avenue, Boston, MA 02115, USA.
Belinda Wang
Weikai Li
Tom A Rapoport
Harvard University · USHoward Hughes Medical Institute · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Structural and Biochemical Basis of the Vitamin K cycleR00HL097083 · NHLBI · WASHINGTON UNIVERSITY · PI LI, WEIKAI · 2011 to 2013
$735k
Structural and Biochemical Basis of the Vitamin K cycleK99HL097083 · NHLBI · HARVARD MEDICAL SCHOOL · PI LI, WEIKAI · 2009 to 2010
$180k
Howard Hughes Medical InstituteNHLBI NIH HHS 1K99HL097083NHLBI NIH HHS K99 HL097083NHLBI NIH HHS R00 HL097083NIGMS NIH HHS T32 GM007753NIGMS NIH HHS T32GM07753
6 · The paper itself

Abstract

Vitamin K epoxide reductase (VKOR) sustains blood coagulation by reducing vitamin K epoxide to the hydroquinone, an essential cofactor for the gamma-glutamyl carboxylation of many clotting factors. The physiological redox partner of VKOR remains uncertain, but is likely a thioredoxin-like protein. Here, we demonstrate that human VKOR has the same membrane topology as the enzyme from Synechococcus sp., whose crystal structure was recently determined. Our results suggest that, during the redox reaction, Cys43 in a luminal loop of human VKOR forms a transient disulfide bond with a thioredoxin (Trx)-like protein located in the lumen of the endoplasmic reticulum (ER). We screened for redox partners of VKOR among the large number of mammalian Trx-like ER proteins by testing a panel of these candidates for their ability to form this specific disulfide bond with human VKOR. Our results show that VKOR interacts strongly with TMX, an ER membrane-anchored Trx-like protein with a unique CPAC active site. Weaker interactions were observed with TMX4, a close relative of TMX, and ERp18, the smallest Trx-like protein of the ER. We performed a similar screen with Ero1-alpha, an ER-luminal protein that oxidizes the Trx-like protein disulfide isomerase. We found that Ero1-alpha interacts with most of the tested Trx-like proteins, although only poorly with the membrane-anchored members of the family. Taken together, our results demonstrate that human VKOR employs the same electron transfer pathway as its bacterial homologs and that VKORs generally prefer membrane-bound Trx-like redox partners.

Indexed as

AnimalsBacterial ProteinsCatalytic DomainChlorocebus aethiopsCOS CellsElectron TransportEndoplasmic ReticulumHumansIn Vitro TechniquesMixed Function OxygenasesMutagenesis, Site-DirectedOxidation-ReductionRecombinant ProteinsSpecies SpecificityStructural Homology, ProteinSynechocystisBacterial ProteinsMixed Function OxygenasesRecombinant ProteinsThioredoxinsVitamin K Epoxide Reductases

Identifiers

PMID20696932
PMCPMC2930587
OpenAlexW2102248384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.